Symptom Management in Inflammatory Bowel Disease

    April 2015 in “ Expert Review of Gastroenterology & Hepatology ”
    Bincy Abraham
    Image of study
    TLDR Effective symptom management in IBD improves quality of life and prevents complications.
    The document from April 23, 2015, provides a detailed review of symptom management in patients with inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). It emphasizes the importance of prompt symptom management to prevent permanent sequelae and improve quality of life. The review discusses the multifactorial nature of symptoms, which can arise from active disease, medication side effects, immunosuppression, extraintestinal manifestations, or concomitant autoimmune disorders. Specific symptoms such as diarrhea, abdominal pain, joint pain, nausea/vomiting, fatigue, psychological issues, dyspnea, neurological symptoms, and alopecia are addressed, with various management strategies outlined for each. The document highlights the need for gastroenterologists to differentiate the causes of symptoms and suggests that future gut-targeted therapies may reduce complications. It also stresses the importance of regular monitoring for nutritional deficiencies and vaccinations as preventive strategies. The review includes discussions on the prevalence of Clostridium difficile infection in hospitalized IBD patients, the impact of C. difficile colitis on health outcomes, and the management of IBD-related symptoms, including the use of antibiotics, prebiotics, probiotics, and fecal microbiota transplantation. It also covers the effects of drugs on ileostomy output, bile acid malabsorption treatments, pain management strategies, the association of nonsteroidal anti-inflammatory drugs with IBD flare-ups, the use of narcotics, and the prevalence of opioid use and extraintestinal manifestations in IBD patients. Lastly, it reviews the efficacy and adverse effects of various IBD treatments and addresses misconceptions in the diagnosis and management of anemia in IBD patients.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community 1% cetirizine (available in allergy medicines) for androgenetic alopecia

       50 upvotes 4 years ago
      The conversation discusses using 1% cetirizine, an antihistamine, as a potential treatment for androgenetic alopecia (hair loss). One user plans to try cetirizine instead of finasteride, while others are curious or skeptical about its effectiveness, discussing the role of inflammation in hair loss.
      Is this a male pattern baldness or diffuse baldness?

      community Is this a male pattern baldness or diffuse baldness?

      in General  144 upvotes 3 months ago
      A 23-year-old male experienced sudden hair loss over six months, losing about 30% of his hair. Treatments include 10% minoxidil, a hair spray, and a vitamin pill; opinions on the cause vary between normal hair loss due to deficiencies and male pattern baldness.

      community Triple Hair TH-16 released. Thoughts and opinions?

      in Product  35 upvotes 3 years ago
      Triple Hair's TH-16, a product claimed to be more effective than Minoxidil 5%, has been released; it contains melatonin and resveratrol. One user reported success with topical melatonin and dermarolling.

    Related Research

    1 / 1 results